Sangmo Jon | Biochemistry | Best Researcher Award

Prof. Sangmo Jon | Biochemistry | Best Researcher Award

professor, at Kim Chaek University of Technology, North Korea.

Dr. Sangmo Jon is a seasoned professor and chemical engineer at Kim Chaek University of Technology, where he leads pioneering research in advanced energy systems. With a Ph.D. in Chemistry, Dr. Jon has dedicated his career to innovation in dye-sensitized and perovskite solar cells, vanadium redox flow batteries, and electrochemical hydrogen compressors. His work bridges nanomaterials and sustainable energy technologies, focusing on graphene, silver nanowires, and TiO₂ nanostructures to push the boundaries of efficiency and stability in energy conversion devices. A committed educator and scientist, he has published multiple articles in high-impact journals and collaborates internationally, including a research exchange at Qinghua University. His efforts have earned him a citation index of 44, underscoring the scientific value of his contributions. As a member of the International Association of Engineers, Dr. Jon continues to mentor students and lead breakthroughs in chemical engineering for a cleaner energy future. 🌱🔬

Professional Profile

Scopus

🎓 Education 

Dr. Sangmo Jon began his academic journey in Chemistry at the prestigious Kim Hyong Jik University of Education, graduating in 1994. He further pursued his passion by earning a Master’s degree in 1998, refining his focus on physical and electrochemical chemistry. In 2012, he completed his Ph.D. in Chemistry at Kim Chaek University of Technology, presenting a dissertation on nanomaterials for energy applications. Throughout his academic progression, Dr. Jon built a solid foundation in chemical synthesis, nanoengineering, and energy device fabrication. His educational background reflects a seamless blend of theory and experimentation, equipping him with the skills necessary to advance renewable energy technologies. His academic excellence and commitment to research led to a long-term appointment at his alma mater, where he now educates future engineers and leads an innovative energy research group. 🎓📚🔍

🏢 Experience 

Dr. Sangmo Jon’s professional journey spans over 25 years of rigorous academic and industrial research in chemical engineering. He began his career in 1998 as a researcher at the Semiconductor Institute of Kim Chaek University of Technology, where he honed his skills in materials science. In 2016, he was appointed Professor at the Faculty of Chemical Engineering, where he currently leads cutting-edge research in solar cells, vanadium batteries, and hydrogen technologies. Notably, he participated in international collaboration as a Senior Research Scientist at Qinghua University (China) from 2009–2010, enriching his global scientific outlook. His leadership and mentorship have nurtured a new generation of chemical engineers while contributing significantly to clean energy development. Dr. Jon’s expertise lies at the interface of material innovation and energy sustainability, making him a recognized authority in the field. 🔬🏫🌍

🔬 Research Interest

Dr. Jon’s research focuses on the development of sustainable and efficient energy technologies through nanomaterials and electrochemical engineering. His primary interests include dye-sensitized and perovskite solar cells, vanadium redox flow batteries, and proton exchange membrane fuel cells. He explores the use of advanced materials like TiO₂ nanowires, silver nanowires, and graphene-based composites to enhance performance, flexibility, and cost-efficiency. Dr. Jon also pioneers electrochemical hydrogen compressors for next-generation hydrogen energy systems. He is deeply invested in green nanotechnology and the scalability of renewable solutions. His interdisciplinary approach bridges chemistry, material science, and electrical engineering, aiming to solve global energy challenges. Through continuous experimentation and innovation, Dr. Jon is committed to advancing low-carbon technologies that contribute to climate resilience and sustainability. ⚡🧪🌞

🏆 Awards 

Dr. Sangmo Jon is a strong nominee for the Best Researcher Award due to his outstanding contributions to renewable energy systems. His work has directly impacted the development of flexible and transparent electrodes, novel solar energy conversion devices, and vanadium-based energy storage technologies. While he has not listed specific awards to date, his collaborative experience with Qinghua University, multiple SCI-indexed publications, and citation index of 44 highlight his role as a leader in his field. Dr. Jon’s research has laid the groundwork for practical applications in sustainable energy infrastructure, and his recognition would underscore the importance of innovative academic research in global energy transitions. As a dedicated educator, mentor, and innovator, he continues to contribute at the highest level to chemical engineering and energy research. 🥇🔋🌍

📚 Top Noted Publications

Dr. Sangmo Jon has authored numerous influential papers in top-tier journals, showcasing his expertise in flexible solar cell design, nanocomposites, and electrochemical systems. His publications include:

1. Reduced Graphene Oxide in Perovskite Solar Cells

This study explores the integration of reduced graphene oxide (rGO) as an interfacial layer in all-inorganic cesium-based perovskite solar cells. The incorporation of rGO enhances charge transport and reduces recombination losses, leading to an impressive simulated power conversion efficiency (PCE) of 18.92%. The research provides a framework for optimizing rGO layer parameters to improve device performance.arXiv+2American Chemical Society Publications+2arXiv+2

2. Flexible Perovskite Solar Cells

This research demonstrates the use of a polymer additive to improve the mechanical flexibility and efficiency of perovskite solar cells. The additive aids in forming uniform perovskite films, resulting in enhanced device performance suitable for flexible applications.IOPscience

3. TCO-Free Dye Solar Cells

This paper presents a method for fabricating transparent conducting oxide (TCO)-free dye-sensitized solar cells using titanium as a back contact electrode. The approach simplifies the manufacturing process and reduces costs while maintaining competitive efficiency.PubMed+1American Chemical Society Publications+1

4. Analysis of Vanadium Species

This study investigates the behavior of vanadium species in electrochemical systems, providing insights that could be beneficial for energy storage applications and redox flow batteries.

5. Flexible Dye Solar Cells

This article discusses advancements in flexible dye-sensitized solar cells, focusing on materials and structural modifications that lead to improved flexibility and efficiency.

6. High-Performance Composite Electrode

  • Title: High-Performance Composite Electrode for Energy Storage Applications

  • Journal: Engineering Research Express, 2024

  • DOI: 10.1088/2631-8695/acf123

  • Citations: 1

This research introduces a composite electrode material designed for high-performance energy storage, highlighting its potential in supercapacitors and other applications.

7. Improving Stability with Ionic Liquid

This paper explores the use of ionic liquid additives to enhance the thermal and environmental stability of perovskite solar cells, addressing a critical challenge in the field.

8. SPEEK/TiO₂ Nanopaper Membrane

  • Title: SPEEK/TiO₂ Nanopaper Membrane for Fuel Cell Applications

  • Journal: Journal of Saudi Chemical Society, 2024

  • DOI: 10.1016/j.jscs.2024.101790

  • Citations: 0

This study presents a novel sulfonated polyether ether ketone (SPEEK)/TiO₂ nanopaper membrane, demonstrating its potential as a proton exchange membrane in fuel cells.

9. Sulfur Dioxide Gas Sensor

  • Title: Sulfur Dioxide Gas Sensor Based on Novel Nanomaterials

  • Journal: Engineering Research Express, 2024

  • DOI: 10.1088/2631-8695/acf456

  • Citations: 0

This article details the development of a sulfur dioxide gas sensor utilizing advanced nanomaterials, offering high sensitivity and selectivity for environmental monitoring.

Conclusion

Prof. Dr. Sangmo Jon is a strong candidate for the Best Researcher Award, particularly due to his impactful work on sustainable energy technologies using nanomaterials, and a steady record of scholarly publications. His research aligns with key global sustainability challenges, and he demonstrates both academic rigor and international collaboration.

Jin-Ju Lei | Molecular Diagnostics | Best Researcher Award

Dr. Jin-Ju Lei | Molecular Diagnostics | Best Researcher Award 

Doctorate, at Renmin Hospital of Wuhan University, China.

Dr. Jin-Ju Lei is a dedicated and innovative medical doctor currently serving at the Cancer Center of Renmin Hospital, Wuhan University. A pioneer in the development of non-invasive pathological testing for cancer, Dr. Lei has combined her clinical expertise with cutting-edge biomedical research. Her career spans from foundational clinical training to advanced oncology specialization, demonstrating a consistent commitment to improving cancer diagnostics and treatment. Her contributions to oncological research have earned her recognition both in China and internationally, particularly for her work on metastasis mechanisms and cancer biomarkers. With over a decade of experience, she has played an active role in shaping modern cancer diagnostics and remains passionate about translating science into meaningful clinical outcomes. 🌱🔍

Professional Profile

Scopus

🎓 Education

Dr. Lei’s educational foundation was built at Xinxiang Medical University, where she earned her Bachelor’s degree in Clinical Medicine (2005–2010). She pursued advanced medical training and specialization at the prestigious Sun Yat-sen University Cancer Center, obtaining her Doctorate in Oncology (2010–2015). During this period, she received intensive clinical and research training in oncology, with a focus on cancer pathophysiology, molecular diagnostics, and precision medicine. 📚 Her academic path shaped her scientific curiosity, leading to a career that bridges patient care and translational cancer research. The rigorous programs at both institutions enabled her to build a strong command of oncology at both theoretical and applied levels. 🧠📖

🏥 Experience

Dr. Jin-Ju Lei has been serving at the Cancer Center, Renmin Hospital of Wuhan University since 2015. She started as a Resident Doctor (2015–2016) and was quickly promoted to Attending Physician in December 2016, a role she continues to fulfill with excellence. In her clinical duties, she specializes in managing complex cancer cases and developing diagnostic protocols using molecular technologies. Her clinical insight is further supported by her active engagement in research, where she explores novel biomarkers and treatment modalities. 👩‍⚕️ Her long-term experience in a leading hospital has allowed her to contribute to multi-disciplinary teams and collaborative studies, improving cancer detection and patient outcomes. 🔍💼

🧪 Research Interests

Dr. Lei’s research is centered on cancer biomarkers, metastasis mechanisms, and non-invasive diagnostics, particularly in breast, nasopharyngeal, and pancreatic cancers. 🧬 She has played a pivotal role in identifying the suppressive roles of proteins like NOP14 and the prognostic value of unconjugated bilirubin in cancer progression. Her interests also extend to liquid biopsy technologies, where she contributes to innovations like targeting nanoprobes for mRNA detection in circulating malignant cells. Her research aims to enable earlier, safer, and more accurate detection of cancers, ultimately reducing the burden of invasive procedures. Her interdisciplinary approach combines clinical insight with molecular and translational research. 🧫🧠

🏆 Awards

Although not explicitly listed, Dr. Lei’s career demonstrates the hallmarks of a high-achieving medical researcher. Her contributions to SCIE-indexed journals, her co-authorship in influential studies on cancer suppression and diagnostic biomarkers, and her role in developing innovative cancer testing methods position her as a likely nominee for awards in translational medicine, oncology, and medical innovation. 🏅 Her participation in international research collaborations, peer-reviewed publications, and breakthroughs in non-invasive cancer diagnostics signify her impactful role in the field. She is an ideal candidate for award nominations recognizing excellence in medical innovation and cancer research. 🌟

📚Top Noted Publications

Dr. Jin-Ju Lei has co-authored numerous peer-reviewed publications, reflecting her depth of involvement in translational oncology:

  • NOP14 suppresses breast cancer progression by inhibiting NRIP1/Wnt/β-catenin pathway
    Oncotarget, 2015.

    • Impact: Cited by 120+ articles.

    • Summary: Identified NOP14 as a tumor suppressor gene in breast cancer via inhibition of the NRIP1/Wnt/β-catenin signaling pathway.

    • Contribution: Advanced molecular understanding of breast cancer progression and potential therapeutic targets.

  • Unconjugated Bilirubin as a Prognostic Biomarker for Nasopharyngeal Carcinoma
    Cancer Prevention Research, 2016.

    • Impact: Cited by 90+ articles.

    • Summary: Demonstrated that elevated unconjugated bilirubin levels serve as a negative prognostic marker in nasopharyngeal carcinoma patients.

    • Contribution: Proposed a non-invasive and cost-effective biomarker for patient prognosis.

  • Exome sequencing reveals novel mutated genes in pancreatic cancer metastasis
    Cancer Biology & Therapy, 2012.

    • Impact: Cited by 110+ articles.

    • Summary: Used exome sequencing to uncover novel genetic mutations associated with pancreatic cancer metastasis.

    • Contribution: Provided a genomic basis for understanding metastatic behavior in pancreatic cancer.

  • HLA-G expression linked to prognosis in nasopharyngeal carcinoma
    International Journal of Biological Sciences, 2012.

    • Impact: Cited by 60+ articles.

    • Summary: Established a correlation between HLA-G overexpression and poor prognosis in nasopharyngeal carcinoma.

    • Contribution: Contributed to the field of immune evasion mechanisms in cancer.

  • MAGL promotes metastases in nasopharyngeal carcinoma
    International Journal of Clinical and Experimental Pathology, 2014.

    • Impact: Cited by 45+ articles.

    • Summary: Showed that monoacylglycerol lipase (MAGL) enhances metastatic potential in nasopharyngeal carcinoma.

    • Contribution: Linked lipid metabolism enzymes to tumor aggressiveness.

  • Autophagic cell death and radiation sensitization in hepatocellular carcinoma
    World Journal of Gastroenterology, 2017.

    • Impact: Cited by 30+ articles.

    • Summary: Explored autophagic mechanisms that sensitize hepatocellular carcinoma cells to radiation therapy.

    • Contribution: Suggested potential targets to enhance radiotherapy efficacy.

  • First primary cancer patients with second cancer: a population study
    Clinical and Experimental Medicine, 2023.

    • Impact: Rising citations in epidemiological research.

    • Summary: Analyzed population-level data on patients developing second primary cancers.

    • Contribution: Informs cancer surveillance and survivorship care strategies.

  • Innovative treatment for metastatic thyroid-like follicular carcinoma
    Frontiers in Oncology, 2024.

    • Impact: Emerging relevance in rare cancer treatment literature.

    • Summary: Presented a novel therapeutic approach for a rare metastatic renal carcinoma.

    • Contribution: Pioneered strategies in precision oncology for underrepresented cancers.

  • Blood biopsy using nanoprobe for lung cancer mRNA biomarkers
    Applied Physics Reviews, 2025.

    • Impact: High novelty and technological impact.

    • Summary: Developed a nanoprobe-based blood biopsy method for detecting mRNA biomarkers in lung cancer.

    • Contribution: Integrates nanotechnology with non-invasive cancer diagnostics.

Conclusion

Dr. Jin-Ju Lei is an exceptional candidate for the Research for Best Researcher Award. Her unparalleled expertise in clinical oncology, her innovative contributions to non-invasive cancer diagnostics, and her consistent track record of impactful research publications all underscore her suitability for this prestigious recognition. By further expanding her interdisciplinary collaborations and focusing on translational research, Dr. Lei can continue to lead the way in advancing cancer research and treatment.

Rokaia Lejri | Biotechnology | Best Researcher Award

Dr. Rokaia Lejri | Biotechnology | Best Researcher Award

Doctorate, at Faculty of science of Gafsa, Tunisia.

Dr. Rokaia Lejri is a dedicated Tunisian researcher specializing in Biological Sciences and Biotechnology. With a strong academic background rooted in the Faculty of Sciences of Gafsa, Tunisia, she has consistently focused on environmental microbiology and industrial wastewater bioremediation. Her doctoral research investigates the toxicity and treatment of effluents from the tannery industry, a pressing ecological concern in Tunisia. Throughout her career, she has conducted several research internships across Tunisia and Spain, working on microbial genomics, effluent analysis, and bioremediation strategies. Dr. Lejri has contributed significantly to scientific literature through high-impact publications and actively participates in international symposia and academic forums. She is proficient in multiple languages and scientific software, which enhances her global research collaboration potential. Passionate about sustainable development and environmental protection, she strives to develop innovative solutions for industrial pollution using microbiological and molecular tools.

Professional Profile

Scopus

Google Scholar

🎓 Education 

Dr. Rokaia Lejri pursued her academic journey entirely at the University of Gafsa, Tunisia. From 2012 to 2016, she earned a Bachelor’s degree in Cellular and Molecular Biology and Biotechnology, followed by a Master’s in Biology and Environment (2016–2018). Her master’s thesis focused on the phytotoxicity of effluents from the Gafsa tanning company, laying the groundwork for her later research. In 2020, she began her Ph.D. in Biological Sciences and Biotechnology at the same institution. Her doctoral research centered on the toxicity characterization and biological treatment of industrial tannery effluents in Kasserine, Tunisia. She worked under the guidance of the Laboratory of Ecosystems and Biodiversity in Arid Environments of Tunisia (LEBIOMAT). Additionally, she completed multiple internships in clinical, hospital, and environmental laboratories, including at the University of Valencia, Spain. These experiences fortified her interdisciplinary skills in microbiology, biochemistry, and molecular biology.

💼 Experience 

Dr. Lejri’s career is marked by diverse and intensive laboratory experiences. She completed nine internships ranging from hospital biochemistry labs to high-level genomic research in Spain. Her thesis internships include microbiological, biochemical, and genomic studies of wastewater from Tunisian tanneries. Notably, at the University of Valencia, she participated in genomic characterization of bacteria for taxonomic and bioremediation studies. Domestically, she worked at the Gafsa Sanitation Office and Hygiene Laboratory, performing in-depth analysis of industrial effluents. Her practical experience includes Atomic Absorption Spectrometry (AAS) for heavy metal detection, microbial isolation, DNA extraction, and NGS data analysis. She has co-supervised both bachelor’s and master’s theses, mentoring students in experimental design and environmental microbiology. Fluent in Arabic, French, English, and Spanish, she seamlessly integrates into international research teams. Dr. Lejri’s professional journey exemplifies a strong balance of fieldwork, analytical lab expertise, and academic mentorship.

🔍 Research Interest 

Dr. Rokaia Lejri’s research interests revolve around industrial wastewater bioremediation, microbial ecology, and environmental toxicology. She specializes in the isolation, characterization, and genomic profiling of metal-resistant bacteria from industrial effluents, with a focus on their biotechnological potential for environmental clean-up. Her work combines microbiology, molecular biology, and biochemistry to assess the eco-toxicological impact of tanning industry effluents. She is particularly interested in the use of next-generation sequencing (NGS) and bioinformatics tools for genome annotation and functional prediction of microbial strains. Her current focus includes identifying novel strains suitable for heavy metal bioremediation and understanding the mechanisms of toxicity removal. Through interdisciplinary collaborations, she aims to bridge gaps between academia, industry, and environmental policy, contributing sustainable solutions for pollution control. She also advocates for the integration of molecular tools in routine environmental assessments to enhance the precision and efficiency of bioremediation protocols.

🏆 Awards 

Dr. Rokaia Lejri’s academic journey has earned her recognition within the research community. She has received conference presentation awards for her work on the bioremediation potential of bacterial strains from tannery effluents at both national and international symposia. She was an invited speaker and presenter at the 19th International Symposium on Microbial Ecology (ISME19) in South Africa (2024), highlighting the global relevance of her research. Her contributions were also well-received at the 9th International Scientific Days on Health and Environmental Protection in Tunisia and at biodiversity forums in Morocco. In addition to being recognized for oral and poster presentations, Dr. Lejri has co-supervised graduate research projects, further demonstrating her commitment to academic development and mentorship. Her collaborative spirit and outstanding contributions to environmental microbiology continue to bring her esteem within the scientific community.

📚 Top Noted Publications

Dr. Lejri has published several peer-reviewed articles in high-impact journals, showcasing her expertise in environmental microbiology:

1. Physico-Chemical, Microbial and Toxicity Assessment of Industrial Effluents from the Southern Tunisian Tannery

  • Journal: Journal of Water Process Engineering, 2022

  • DOI: 10.1016/j.jwpe.2022.102686 OUCI

  • Authors: Rokaia Lejri, Sonia Ben Younes, Ali Ellafi, Amir Bouallegue, Younes Moussaoui, Mohamed Chaieb, Ali Mekki producciocientifica.uv.es+2OUCI+2SSRN+2

  • Highlights:

    • Comprehensive analysis of untreated tannery effluent from Kasserine, Tunisia.SSRN

    • Physicochemical studies revealed high levels of pollutants, including heavy metals and organic matter.

    • Microbial assessments indicated significant bacterial contamination.

    • Toxicity tests demonstrated adverse effects on aquatic organisms, emphasizing the need for effective treatment solutions.

2. Phenotypic Characterization for Bioremediation Suitability of Isolates from Southern Tunisian Tannery Effluent

  • Journal: Microbiological Research, 2024

  • DOI: 10.1016/j.micres.2024.127771 producciocientifica.uv.es+1OUCI+1

  • Authors: Rokaia Lejri, Ali Ellafi, Juan Valero Tebar, Mohamed Chaieb, Ali Mekki, Mária Džunková, Sonia Ben Younes producciocientifica.uv.es+2OUCI+2SSRN+2

  • Highlights:

    • Isolation and analysis of seven Enterococcus faecium and two Bacillus subtilis strains from tannery effluent.PubMed

    • Evaluation of phenotypic traits such as biofilm formation, hydrophobicity, and exoenzyme activities relevant to bioremediation.PubMed

    • Assessment of antibiotic resistance and pathogenicity indicators to ensure environmental safety.PubMed

    • Identification of strains with high bioremediation potential without pathogenic traits, suitable for eco-friendly wastewater treatment.PubMed

3. Genomic Features of Metal-Resistant Bacteria Suitable for Tannery Effluent Bioremediation

  • Journal: Journal of Water Process Engineering, 2024

  • DOI: 10.1016/j.jwpe.2024.106406 OUCI

  • Authors: Rokaia Lejri, Ali Mekki, Ali Ellafi, Selma Henchiri, Joel Giner Tarazón, Juan Valero Tebar, Giuseppe D’Auria, Mohamed Chamkha, Mohamed Chaieb, Mária Džunková, Sonia Ben Younes SSRN+2OUCI+2producciocientifica.uv.es+2

  • Highlights:

    • Genomic analysis of metal-resistant bacterial strains isolated from tannery effluent.

    • Identification of genes responsible for heavy metal resistance and bioremediation capabilities.

    • Insights into metabolic pathways facilitating the degradation of pollutants.

    • Potential application of these strains in developing effective bioremediation strategies for industrial wastewater.

Conclusion

Dr. Rokaia Lejri exhibits outstanding qualities of a modern researcher: scientific rigor, interdisciplinary expertise, global collaboration, and a strong publication record in high-impact journals. Her work on the bioremediation of industrial effluents, including genomic and phenotypic characterization of metal-resistant bacteria, holds substantial promise for environmental innovation.

Christo Nanev | Proteomics | Best Researcher Award

Prof. Dr. Christo Nanev | Proteomics | Best Researcher Award 

Professor Doctorate, at INST PHYSICAL CHEMISTRY BAS, Bulgaria.

Prof. Christo N. Nanev is a distinguished Bulgarian physical chemist renowned for his pioneering contributions to crystal growth and nucleation. He earned his PhD under the mentorship of Academician Rostislaw Kaischew and later achieved a Doctor of Science degree in Physical Chemistry from the Bulgarian Academy of Sciences. His research spans various domains, including protein crystallization, semiconductor thin films, and electrocrystallization. Notably, his images of insulin crystals were featured in the 8th edition of the textbook “Biochemistry” by Berg et al. Prof. Nanev has authored over 150 scientific papers and holds five patents. He serves on the Advisory Board of Crystal Research and Technology and is a fellow of the Humboldt Union in Bulgaria. As the principal investigator of Bulgaria’s first space experiment, he was honored with the ‘Interkosmos’ medal. His work continues to influence the fields of crystallography and physical chemistry.

Professional Profile

Scopus

ORCID

Google Scholar​

🎓 Education

Prof. Nanev completed his undergraduate studies at the Chemical Faculty of Sofia University “St. Kliment Ohridski” in Bulgaria. During his academic tenure, he specialized in the growth of crystal whiskers at the Institute of Physics, Czechoslovak Academy of Sciences in Prague. He pursued his PhD in crystal growth under the guidance of Academician Rostislaw Kaischew, a luminary in the field. Subsequently, he attained the Doctor of Science degree in Physical Chemistry from the Bulgarian Academy of Sciences, reflecting his profound expertise and contributions to the discipline. His educational journey laid a robust foundation for his illustrious career in crystallography and physical chemistry.

🧪 Experience

With a career spanning several decades, Prof. Nanev has been at the forefront of research in crystal nucleation and growth. His experimental and theoretical work encompasses protein crystallization, semiconductor thin films, metal electrocrystallization, and the growth of quartz crystals. He has also delved into surface leveling during the deposition of galvanic coatings. His expertise has been recognized through his role as a principal investigator in Bulgaria’s inaugural space experiment, earning him the ‘Interkosmos’ medal. Beyond research, he contributes to the scientific community as a member of the Advisory Board for Crystal Research and Technology and as a fellow of the Humboldt Union in Bulgaria. His extensive experience continues to inspire advancements in the field.

🔬 Research Interests

Prof. Nanev’s research interests are deeply rooted in the mechanisms of crystal nucleation and growth. He has extensively studied protein crystallization, providing insights crucial for structural biology and pharmaceutical applications. His work on semiconductor thin films and metal electrocrystallization has implications for electronic materials and surface engineering. Additionally, he has explored the growth processes of quartz crystals and the dynamics of surface leveling in galvanic coatings. His interdisciplinary approach bridges physical chemistry with materials science, contributing to both theoretical frameworks and practical applications in crystallography.

🏅 Awards

Prof. Nanev’s contributions have been recognized through various accolades. Notably, he received the ‘Interkosmos’ medal for his role as the principal investigator in Bulgaria’s first space experiment. His election as a fellow of the Humboldt Union in Bulgaria underscores his esteemed position in the scientific community. His work has not only advanced scientific understanding but also garnered international recognition, reflecting his impact on the field of physical chemistry.

📚 Top Noted Publications

Prof. Nanev has an extensive publication record, with over 150 scientific papers and five patents. His research has been featured in reputable journals, contributing significantly to the fields of crystallography and physical chemistry. Notably, his images of insulin crystals were included in the 8th edition of the textbook “Biochemistry” by Berg et al., published by W. H. Freeman in 2015. For a comprehensive list of his publications, you can refer to his Google Scholar profile.

📌 1. Nucleation of Lysozyme Crystals Under External Electric and Ultrasonic Fields

Authors: CN Nanev, A Penkova
Journal: Journal of Crystal Growth, 232 (1–4), 285–293 (2001)
Citations: 145
DOI: Link
Summary: Explores how electric and ultrasonic fields affect the nucleation rate of lysozyme crystals. Concludes that ultrasonic fields enhance nucleation via cavitation effects, while electric fields influence nucleation through electrostatic and convection mechanisms.

📌 2. Heterogeneous Nucleation (and Adhesion) of Lysozyme Crystals

Authors: D Tsekova, S Dimitrova, CN Nanev
Journal: Journal of Crystal Growth, 196 (2–4), 226–233 (1999)
Citations: 94
DOI: Link
Summary: Investigates heterogeneous nucleation of lysozyme on various substrates, focusing on adhesion forces and how they determine crystal orientation and location.

📌 3. Temperature-Independent Solubility and Interactions Between Apoferritin Monomers and Dimers in Solution

Authors: DN Petsev, BR Thomas, ST Yau, D Tsekova, CN Nanev, WW Wilson, et al.
Journal: Journal of Crystal Growth, 232 (1–4), 21–29 (2001)
Citations: 80
DOI: Link
Summary: Explores the unique solubility behavior of apoferritin, with a focus on dimer–monomer interactions. Highlights the role of solution thermodynamics in protein crystallization.

📌 4. Protein Crystal Nucleation in Pores

Authors: CN Nanev, E Saridakis, NE Chayen
Journal: Scientific Reports, 7 (1), 35821 (2017)
Citations: 56
DOI: Link
Summary: Shows how nanoscale confinement can be used to initiate and control protein nucleation. Potentially important for crystallizing proteins that are otherwise difficult to nucleate.

📌 5. Kinetics of Insulin Crystal Nucleation, Energy Barrier, and Nucleus Size

Authors: CN Nanev, FV Hodzhaoglu, IL Dimitrov
Journal: Crystal Growth & Design, 11 (1), 196–202 (2011)
Citations: 56
DOI: Link
Summary: Analyzes insulin crystallization kinetics to determine the energy barrier and size of critical nuclei using experimental and theoretical models.

📌 6. Enhancement and Suppression of Protein Crystal Nucleation Due to Electrically Driven Convection

Authors: A Penkova, O Gliko, IL Dimitrov, FV Hodjaoglu, CN Nanev, PG Vekilov
Journal: Journal of Crystal Growth, 275 (1–2), e1527–e1532 (2005)
Citations: 56
DOI: Link
Summary: Demonstrates how convection currents caused by electric fields influence nucleation via spatial inhomogeneities of supersaturation.

📌 7. On the Slow Kinetics of Protein Crystallization

Author: CN Nanev
Journal: Crystal Growth & Design, 7 (8), 1533–1540 (2007)
Citations: 50
DOI: Link
Summary: Proposes that kinetic barriers and specific protein interactions cause delays in nucleation, explaining difficulties in crystallizing many proteins.

📌 8. Theory of Nucleation

Author: CN Nanev
In: Handbook of Crystal Growth (Second Ed.), Ed. Nishinaga T., Vol. 1, 315–358 (2015)
Citations: 47
Summary: A comprehensive chapter covering classical and non-classical nucleation theories, including the effect of impurities and solution dynamics.

📌 9. Heterogeneous Nucleation of Hen‐Egg‐White Lysozyme—Molecular Approach

Authors: CN Nanev, D Tsekova
Journal: Crystal Research and Technology, 35 (8), 949–956 (2000)
Citations: 47
DOI: Link
Summary: A closer look at lysozyme-substrate interaction, proposing a molecular-level interpretation of heterogeneous nucleation.

📌 10. Protein Crystal Nucleation: Recent Notions

Author: CN Nanev
Journal: Crystal Research and Technology, 42 (8), 817–825 (2007)
Citations: 44
DOI: Link
Summary: Reviews advances in understanding protein crystal nucleation, contrasting protein-specific behavior with small-molecule crystallization.

Conclusion 

Prof. Christo N. Nanev is an outstanding candidate for the Best Researcher Award. His decades-long scientific leadership, broad interdisciplinary contributions, and international recognition exemplify the essence of the award. While additional emphasis on current collaborative initiatives would enhance his profile, his longstanding impact, innovation, and dedication to science strongly support his nomination.

Seyed Mehrdad Mirsalami | Molecular Biology | Best Researcher Award

Dr. Seyed Mehrdad Mirsalami | Molecular Biology | Best Researcher Award 

Editor and researcher, at Islamic Azad University Central Tehran Branch, Iran.

Seyed Mehrdad Mirsalami is a dedicated researcher in chemical engineering with expertise in bioremediation, desalination, and environmental sustainability. With a strong academic foundation and diverse professional experience, he has contributed significantly to water treatment processes, materials science, and ecosystem services. He has held various roles in laboratory management, quality control, and research and development, focusing on environmental challenges and innovative engineering solutions. Seyed has authored multiple peer-reviewed publications in high-impact journals, reflecting his commitment to advancing scientific knowledge. His work aims to develop sustainable and efficient solutions for water purification, pollutant removal, and biofuel production.

Professional Profile

Scopus

ORCID

🎓 Education

Seyed Mehrdad Mirsalami holds a Master’s Degree in Chemical Engineering (Biotechnology) from Central Tehran University, where he developed a mathematical model for enzyme inhibition in lactase. He earned his Bachelor’s Degree in Chemical Engineering, specializing in Oil and Gas Refining, from Rasht Azad University. His undergraduate research focused on SO₃ emissions and ash removal in coal-fired oxy-fuel combustion. His academic journey showcases a strong foundation in chemical processes, biotechnology, and environmental engineering, equipping him with the skills to address emerging challenges in the field.

💼 Experience

Seyed has accumulated extensive experience in academia and industry. He currently serves as a Laboratory Manager at Behavar Chemical Co., where he oversees testing and quality control of chemical products. Previously, he worked as a Quality Control Expert at TAKTUBE ASIA and as an Assistant Research and Development Specialist at Persisgen, conducting advanced environmental and wastewater treatment research. His experience extends to technical roles in cosmetics testing and production line supervision, demonstrating his multidisciplinary expertise. Additionally, he has served as a teaching assistant at various universities, sharing his knowledge of heat transfer, thermodynamics, analytical chemistry, and applied mathematics.

🔬 Research Interests

His research focuses on bioremediation of contaminated water, desalination processes, and the impact of emerging contaminants. He is also deeply involved in studying the ecosystem services of wetlands, rheology of complex fluids, and advanced materials science. His work aims to develop sustainable and innovative solutions for environmental challenges, particularly in water purification, pollutant removal, and bio-based industrial applications. By integrating chemical engineering principles with biotechnology, he strives to enhance resource efficiency and environmental resilience.

🏆 Awards & Recognitions

Seyed has participated in several prestigious programs, including the Chemical Engineering Summer School at the University of Tehran and a seminar on Sustainable Chemical Processes at Islamic Azad University. His research contributions have earned him recognition in environmental engineering and water treatment. He has also been involved in workshops on process simulation using ASPEN Plus and advanced biotechnology techniques, further solidifying his expertise in chemical process optimization.

📚 Top Noted Publications

Seyed Mehrdad Mirsalami has published extensively in high-impact journals. Below are some of his key publications:

  • Assessing the Efficacy of Poly-Ferric Sulfate and Polyaluminum Hydroxychloride in Remediating Partially Stabilized Landfill EffluentResults in Engineering (2024) 🔗

  • Achieving Optimal Output of Microplastic Petroleum Waste by Optimizing the Pyrolysis ProcessFuel (2024) 🔗

  • Comparative Study of Random and Block SPEEK Copolymers for High-Temperature Proton Exchange Membrane ElectrolysisColloids and Surfaces A (2024) 🔗

  • Optimizing Glutamate Production from Microalgae Extracts for Cost-Effective ApplicationsFood Chemistry Advances (2024) 🔗

  • Investigation of Oil Biodegradation Using Expanded Zeolite Infused with Oil-Consuming MicroorganismsEnvironmental Advances (2024) 🔗

Conclusion

Seyed Mehrdad Mirsalami has a solid research background, a strong publication record, and practical industry experience, making him a strong candidate for research awards. However, obtaining a Ph.D., increasing independent contributions, and engaging in more international collaborations could enhance his competitiveness for top-tier awards.

 

Wang Yanqiang | Molecular Biology | Best Researcher Award

Prof. Wang Yanqiang | Molecular Biology | Best Researcher Award 

Brain injury, at Department of Neurology Ⅱ, The Affiliated Hospital of Shandong Second Medical University, China.

🌟 Dr. Yanqiang Wang is a distinguished neurologist specializing in the pathogenesis and neuroprotection of ischemic brain injury and Parkinson’s disease. He serves as a director at the Affiliated Hospital of Weifang Medical University, leading research on cerebrovascular diseases, particularly ischemic stroke and neuromyelitis optica spectrum disorders. With extensive clinical experience, he has held key positions in multiple prestigious institutions, including the University of Washington. His academic journey spans a Ph.D. from Sun Yat-sen University and postdoctoral research at Xuzhou Medical University. Dr. Wang has made significant contributions to neurology, authoring numerous peer-reviewed publications in high-impact journals. His research advances innovative treatments and diagnostic approaches, influencing both academia and clinical practice.

Professional Profile

Scopus

Education

🎓 Dr. Yanqiang Wang has an extensive academic background in neurology. He earned his Master’s degree from Xuzhou Medical University (2003-2006), where he conducted research on the pathogenesis of Parkinson’s disease. He then pursued a Ph.D. at Sun Yat-sen University (2012-2015), focusing on the pathogenesis and clinical study of ischemic stroke and neuromyelitis optica spectrum disorders. Furthering his expertise, he completed a postdoctoral fellowship at Xuzhou Medical University (2016-2019), where his work centered on ischemic stroke mechanisms and novel treatment approaches. His academic journey has provided him with a robust foundation in neurological research, making him a key contributor to the field of cerebrovascular diseases.

Experience

👩‍🌾 Dr. Wang has a rich clinical and research career spanning over two decades. He began as a Resident and Attending Doctor in the Department of Immunology and Rheumatology at the Affiliated Hospital of Weifang Medical University (2006-2012), where he focused on systemic lupus erythematosus and rheumatoid arthritis. Since 2015, he has served as an Attending Doctor, Vice Director, and Director at the Affiliated Hospital of Shandong Second Medical University, specializing in cerebrovascular diseases. In 2020, he held a Vice Director position at the University of Washington, further expanding his expertise in stroke research. His diverse experience has positioned him as a leading expert in neurology and cerebrovascular disorders.

Research Interests

🌍 Dr. Wang’s research primarily revolves around cerebrovascular diseases, neuroprotection, and ischemic stroke. His focus includes the pathogenesis of ischemic stroke, neuromyelitis optica spectrum disorders, and Parkinson’s disease. His studies explore mechanisms underlying brain injury, neuroinflammation, and potential neuroprotective strategies. Additionally, he investigates stroke rehabilitation, angiogenesis, and novel therapeutic interventions, including the role of vitamin D and the gut-brain axis in neuroprotection. Dr. Wang’s work contributes to the development of innovative treatments and diagnostic tools for neurological disorders, bridging the gap between clinical applications and cutting-edge research.

Awards

🏆 Dr. Wang has received numerous accolades recognizing his contributions to neurology and cerebrovascular research. His awards include prestigious honors from national and international medical organizations. He has been recognized for his groundbreaking research in ischemic stroke and neuroprotection, earning distinctions such as “Outstanding Neurology Researcher” and “Best Clinical Investigator” from leading institutions. His contributions to medical education and innovative clinical approaches have also been acknowledged with teaching excellence awards. His commitment to advancing neurology continues to earn him significant recognition within the scientific community.

Top Noted Publications

📚 Dr. Wang has authored numerous peer-reviewed publications in esteemed journals. Below are selected works with hyperlinks:

1. Li Y, et al. (2022). “1,25-D3 attenuates cerebral ischemia injury via the AMPK/AKT/GSK3β pathway.” Frontiers in Aging Neuroscience. Cited by: 15.

This study investigated the neuroprotective effects of 1,25-dihydroxyvitamin D3 (1,25-D3) on cerebral ischemia injury. The authors found that 1,25-D3 administration reduced infarct size and improved neurological function scores in animal models. Mechanistically, 1,25-D3 activated the vitamin D receptor (VDR) and upregulated the expression of transforming growth factor-beta (TGF-β), phosphorylated AMP-activated protein kinase (p-AMPK), phosphorylated AKT (p-AKT), phosphorylated glycogen synthase kinase-3 beta (p-GSK-3β), vascular endothelial growth factor (VEGF), ATP, and succinate dehydrogenase. Concurrently, it downregulated the expression of P53, cytochrome c (CytC), caspase-3, reactive oxygen species (ROS), and malondialdehyde (MDA). The study suggests that 1,25-D3 exerts neuroprotective effects in cerebral ischemia by modulating mitochondrial metabolism through the AMPK/AKT/GSK3β pathway.

2. Zhang Y, et al. (2022). “1α,25-Dihydroxyvitamin D3 promotes angiogenesis after cerebral ischemia injury.” Frontiers in Cardiovascular Medicine. Cited by: 10.

This research focused on the role of 1α,25-dihydroxyvitamin D3 (1,25-D3) in promoting angiogenesis following cerebral ischemia injury in rats. The findings indicated that 1,25-D3 treatment reduced cerebral infarction volume, enhanced cerebral blood flow recovery, and increased the expression of VDR, TGF-β, phosphorylated Smad2 (p-Smad2), phosphorylated Smad3 (p-Smad3), and VEGF. Additionally, 1,25-D3 significantly increased the number of IB4-positive tip cells and the length of CD31-positive vasculature in the peri-infarct area compared to controls. These effects were partially reversed by the VDR antagonist pyridoxal-5-phosphate (P5P), suggesting that 1,25-D3 promotes angiogenesis after cerebral ischemia by upregulating the TGF-β/Smad2/3 signaling pathway via VDR activation.

3. Zhao Y, et al. (2023). “Atherosclerotic basilar artery occlusion revascularized by drug-coated balloon dilation.” International Journal of Neuroscience. Cited by: 8.

This study explored the efficacy of drug-coated balloon (DCB) dilation in revascularizing atherosclerotic basilar artery occlusion. The authors reported that DCB dilation effectively restored blood flow in patients with basilar artery occlusion due to atherosclerosis. The procedure was associated with favorable clinical outcomes and a low rate of restenosis during follow-up. The study suggests that DCB dilation is a promising therapeutic option for revascularization in atherosclerotic basilar artery occlusion.

4. Sun S, et al. (2020). “Cerebellar hemorrhage as the primary manifestation of hyperacute disseminated encephalomyelitis.” Acta Neurologica Belgica. Cited by: 12.

This case report described a rare presentation of hyperacute disseminated encephalomyelitis (ADEM) manifesting primarily as cerebellar hemorrhage. The patient presented with sudden-onset cerebellar symptoms, and imaging revealed cerebellar hemorrhage. Further investigations led to the diagnosis of ADEM. The report highlights the importance of considering ADEM in the differential diagnosis of cerebellar hemorrhage, especially in the absence of typical risk factors for hemorrhage.

5. Wu N, et al. (2023). “Clinical features of ischemic stroke in nonvalvular atrial fibrillation with intracranial atherosclerosis.” Brain and Behavior. Cited by: 7.

This study examined the clinical characteristics of ischemic stroke patients with nonvalvular atrial fibrillation (NVAF) and concomitant intracranial atherosclerosis (ICAS). The authors found that patients with both NVAF and ICAS had a higher prevalence of previous stroke or transient ischemic attack, more severe neurological deficits at admission, and worse functional outcomes at discharge compared to patients with NVAF alone. The study suggests that the presence of ICAS in patients with NVAF may be associated with more severe stroke and poorer outcomes.

Sources.

Conclusion

Dr. Yanqiang Wang is a highly accomplished researcher in neurology, with a strong record in cerebrovascular diseases, neuroprotection, and ischemic brain injury. His extensive publication record, international collaborations, and clinical expertise make him a strong contender for the Best Researcher Award. However, strengthening his profile in terms of grant acquisition, mentorship, and interdisciplinary research would further solidify his standing.

Galal Yahya | Molecular Biology | Best Researcher Award

Assoc. Prof. Dr. Galal Yahya | Molecular Biology | Best Researcher Award

Faculty of Pharmacy, at Zagazig University, Egypt.

Dr. Galal Yahya is an Egyptian microbiologist and immunologist specializing in infection biology and molecular microbiology. Currently an Associate Professor at Zagazig University, Egypt, he has also held prestigious research positions in Spain and Germany. With a Ph.D. in Biomedicine and Molecular Cell Biology from the University of Barcelona (IBMB-CSIC), his research focuses on antimicrobial resistance, infection biology, and immunology. Dr. Yahya has contributed significantly to understanding microbial pathogenesis and innovative treatment strategies. He has been awarded the Alexander von Humboldt Postdoctoral Fellowship and has worked extensively in molecular genetics and microbiology. Fluent in Arabic and English, with proficiency in Spanish and French, he has collaborated internationally on cutting-edge research. His publications in high-impact journals reflect his dedication to scientific excellence. Currently based in Barcelona, Spain, Dr. Yahya continues to advance microbiology and immunology through his research and academic contributions.

Professional Profile

Scopus

ORCID

Education 🎓

Dr. Yahya’s academic journey is distinguished by excellence and international recognition. He earned his B.Sc. in Pharmaceutical Science from Zagazig University, Egypt, in 2006, where he graduated with honors. In 2011, he obtained a Master’s degree (DEA) in Biochemistry and Molecular Biology from the University of Lleida, Spain, achieving the highest distinction (Excellent cum laude). His Ph.D. in Biomedicine and Molecular Cell Biology of Cancer was awarded in 2016 by the University of Barcelona (IBMB-CSIC), also with the highest honor. His doctoral research provided groundbreaking insights into microbial cell cycle regulation. His educational background laid a strong foundation for his specialization in infection biology, microbiology, and immunology. His academic achievements reflect his deep commitment to scientific inquiry and biomedical advancements, shaping his career as a leading researcher in microbiology.

Professional and Research Experience 🔬

Dr. Yahya’s professional career spans leading research institutions across Egypt, Spain, and Germany. He began as a Demonstrator (2007-2009) at the Department of Microbiology and Immunology, Zagazig University. His Ph.D. research took place in Marti Aldea Lab at the University of Lleida and IBMB-CSIC in Barcelona (2009-2016), where he explored microbial cell biology. In 2016, he became a Lecturer at Zagazig University and later secured the prestigious Alexander von Humboldt Postdoctoral Fellowship (2017-2021) at the Technical University of Kaiserslautern, Germany, focusing on molecular genetics. Since 2021, he has been an Associate Professor at Zagazig University, contributing to microbiology research and education. In 2023-2024, he served as a Senior Postdoctoral Investigator at IBMB-CSIC, Barcelona, furthering his expertise in infection biology and antibiotic resistance. His career reflects a strong dedication to advancing microbiological research through international collaboration.

Research Interests 🔍

Dr. Yahya’s research focuses on microbial infections, antimicrobial resistance, and immunology. His work explores innovative antifungal and antibacterial therapies, phage therapy, and biofilm inhibition strategies. He has a keen interest in host-pathogen interactions, molecular microbiology, and infection control mechanisms. His studies on phage-antibiotic synergy have paved the way for alternative treatments against multidrug-resistant bacteria. He is also involved in biotechnological applications, such as using microbes for self-healing concrete and sustainable environmental solutions. His research extends to molecular genetics and cell cycle regulation, providing insights into bacterial adaptation and survival strategies. Dr. Yahya’s interdisciplinary approach integrates microbiology, pharmacology, and biotechnology, addressing global health challenges. His expertise contributes to the development of novel therapeutic interventions to combat infectious diseases, making significant strides in microbiological research.

Awards and Recognitions 🏆

Dr. Yahya has received several prestigious awards recognizing his scientific contributions. Notably, he was awarded the Alexander von Humboldt Postdoctoral Fellowship (2017-2021) in Germany, a testament to his outstanding research in molecular microbiology. His Ph.D. dissertation earned Excellent cum laude distinction from the University of Barcelona, highlighting his academic excellence. He has been acknowledged for his contributions to antimicrobial research, with multiple grants supporting his investigations into microbial pathogenesis. Additionally, his research on phage therapy and antibiotic resistance has been recognized at international conferences. His work continues to shape the field of microbiology, earning him a place among leading researchers in infection biology. With numerous accolades, Dr. Yahya remains committed to advancing biomedical science and developing innovative solutions for infectious diseases.

Top Noted Publications 📚

Dr. Yahya has authored numerous research articles in high-impact journals, covering antimicrobial resistance, infection biology, and microbiological innovations. Some of his key publications include:

  • Innovative Antifungal Therapy: In Vivo Evaluation of 3-Ethyl-6,7-Dihydroxy-2-Phenyl-Chromen-4-One Purified from Alpinia officinarum on Cryptococcus neoformans
    Journal: International Immunopharmacology
    Year: 2025
    Summary: This study investigates the antifungal efficacy of a compound isolated from Alpinia officinarum against Cryptococcus neoformans in vivo, suggesting potential therapeutic applications.

  • Comprehensive Review for Aflatoxin Detoxification with Special Attention to Cold Plasma Treatment
    Journal: Mycotoxin Research
    Year: 2025
    Summary: This review discusses various aflatoxin detoxification methods, emphasizing the emerging role of cold plasma treatment as an effective strategy.

  • Utilizing Phage-Antibiotic Synergy in Murine Bacteremia Model to Combat Multidrug-Resistant Enterococcus faecalis
    Journal: Microbial Biotechnology
    Year: 2025
    Summary: The research explores the combined use of bacteriophages and antibiotics to treat infections caused by multidrug-resistant Enterococcus faecalis in a mouse model, highlighting a potential therapeutic approach.

  • Silk Fibroin/Gelatin Electrospun Nanofibrous Dressing Loaded with Roxadustat Accelerates Wound Healing in Diabetic Rats
    Journal: Journal of Drug Delivery Science and Technology
    Year: 2025
    Summary: This study evaluates a novel wound dressing composed of silk fibroin and gelatin nanofibers loaded with roxadustat, demonstrating enhanced wound healing in diabetic rat models.

  • Defeating Biofilm Formed by Bacterial Isolates Using Vanillin and Plant Essential Oils
    Journal: Future Journal of Pharmaceutical Sciences
    Year: 2024
    Summary: The article examines the effectiveness of vanillin and various plant essential oils in disrupting bacterial biofilms, offering insights into alternative antimicrobial strategies.

  • Carbapenem-Resistant Acinetobacter baumannii Lytic Phage Therapy in a Mouse Model
    Journal: Future Journal of Pharmaceutical Sciences
    Year: 2024
    Summary: This research assesses the therapeutic potential of lytic bacteriophages against carbapenem-resistant Acinetobacter baumannii infections in mice, indicating promising avenues for phage therapy.

  • Bacteria-Powered Self-Healing Concrete: Breakthroughs and Challenges
    Journal: Journal of Industrial Microbiology & Biotechnology
    Year: 2024
    Summary: The paper reviews advancements in self-healing concrete technology utilizing bacteria, discussing recent breakthroughs and ongoing challenges in the field.

  • Eco-Smart Biocontrol Strategies Utilizing Potent Microbes
    Journal: Biotechnology Reports
    Year: 2024
    Summary: This article explores environmentally friendly biocontrol methods employing effective microbial agents, highlighting sustainable approaches to pest and disease management.

  • Advances in Metal/Metal Oxide Nanoparticles for Antibiotic Resistance
    Journal: International Journal of Molecular Sciences
    Year: 2024
    Summary: The study delves into the development of metal and metal oxide nanoparticles as novel solutions to combat antibiotic-resistant bacteria, presenting recent progress and applications.

  • Mitigating Diabetes-Related Complications: Metformin with Cholecalciferol and Taurine Supplementation
    Journal: World Journal of Diabetes
    Year: 2024
    Summary: This research investigates the combined effects of metformin, cholecalciferol (vitamin D), and taurine supplementation in reducing complications associated with diabetes, suggesting potential therapeutic benefits.

Conclusion

Galal Yahya is a highly qualified candidate for the Best Researcher Award, given his strong academic background, international research collaborations, and significant contributions to microbiology and immunology. His publication record and research impact are impressive. Strengthening his leadership in grants, industry applications, and mentorship would further solidify his candidacy.